These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4624585)

  • 1. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of melanophore stimulating hormone (MSH) release.
    Hadley ME; Bower A; Hruby VJ
    Yale J Biol Med; 1973 Dec; 46(5):602-16. PubMed ID: 4544339
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that Pro-Leu-Gly-NH 2 , tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormone.
    Grant NH; Clark DE; Rosanoff EI
    Biochem Biophys Res Commun; 1973 Mar; 51(1):100-6. PubMed ID: 4540644
    [No Abstract]   [Full Text] [Related]  

  • 4. Ability of various factors to oppose the stimulatory effect of dibutyrylcyclic AMP on the release of melanocyte-stimulating hormone by the rat pituitary in vitro.
    Baker BI
    J Endocrinol; 1976 Feb; 68(02):283-7. PubMed ID: 176294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 6. Biogenic amines and control of melanophore stimulating hormone release.
    Bower A; Hadley ME; Hruby VJ
    Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic requirements for melanophore-stimulating hormone (MSH) release.
    Bower A; Hadley ME
    Gen Comp Endocrinol; 1972 Aug; 19(1):147-58. PubMed ID: 4625838
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin).
    Bower A; Hadley ME; Hruby VJ
    Biochem Biophys Res Commun; 1971 Dec; 45(5):1185-91. PubMed ID: 5135504
    [No Abstract]   [Full Text] [Related]  

  • 9. A relationship between adrenergic blockage and the secretory process in cells of the pars intermedia of the frog Rana pipiens.
    Olsson R; Gorbman A
    Gen Comp Endocrinol; 1973 Aug; 21(1):138-47. PubMed ID: 4541986
    [No Abstract]   [Full Text] [Related]  

  • 10. Melanophore and adrenocortical stimulating activities of substances from the pars intermedia, pars distalis, hypothalamus and cerebral cortex of the frog, Rana pipiens.
    Preslock JP; Brinkley HJ
    Life Sci II; 1970 Dec; 9(23):1369-80. PubMed ID: 4321773
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro formation of a MSH-releasing agent by hypothalamic extracts.
    Celis ME; Taleisnik S
    Experientia; 1971 Dec; 27(12):1481-2. PubMed ID: 5144873
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrexone induces melanocyte-stimulating hormone release and degenerative changes in pituitary innervation in amphibians.
    Saland LC; Comunas F; Maez D
    Neuropeptides; 1986; 8(2):133-41. PubMed ID: 3489902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic and cerebral cortical inhibitors of a melanocyte-stimulating substance secreted by the pars distalis of the frog pituitary gland.
    Bercu BB; Brinkley HJ
    Experientia; 1969 Aug; 25(8):879-80. PubMed ID: 4900011
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurohypophysial hormone and the release of luteinizing hormone from bovine pituitary slices in vitro.
    Wilks JW; Hansel W
    J Anim Sci; 1971 Nov; 33(5):1042-7. PubMed ID: 4330395
    [No Abstract]   [Full Text] [Related]  

  • 15. Fine structure of the secretory activity of the pars intermedia of Rana pipiens.
    Perryman EK
    Gen Comp Endocrinol; 1974 May; 23(1):94-110. PubMed ID: 4545363
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of pituitary melanocyte-stimulating hormone by the oxytocin fragment, H-Cys-Tyr-Ile-Gln-Asn-Oh.
    Celis ME; Taleisnik S; Walter R
    Biochem Biophys Res Commun; 1971 Nov; 45(3):564-9. PubMed ID: 4942720
    [No Abstract]   [Full Text] [Related]  

  • 17. Separation of granules containing melanophore stimulating hormone from frog (Rana catesbeiana) pars intermedia.
    Kikuyama S; Yasumasu I
    Endocrinol Jpn; 1972 Dec; 19(6):549-55. PubMed ID: 4541915
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretion of melanophore-stimulating hormone (MSH) in long-term cultures of pituitary neurointermediate lobes.
    Semoff S; Fuller BB; Hadley ME
    Cell Tissue Res; 1978 Nov; 194(1):55-69. PubMed ID: 309795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effect on melanocyte-stimulating hormone release of two neural tissue extracts.
    Taleisnik S; Tomatis ME
    Am J Physiol; 1967 Jan; 212(1):157-63. PubMed ID: 4289089
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of acute and chronic administration of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity.
    Peaslee MH; Goldman M; Milburn SE
    Comp Gen Pharmacol; 1972 Jun; 3(10):191-4. PubMed ID: 4542435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.